Anocca

Sweden
Södertälje, Stockholm, Sweden, 15136

Company profile

Anocca company profile

Anocca is a clinical-stage biopharmaceutical company that develops T-cell receptors to treat infectious and autoimmune diseases. The company does precise and efficient analysis of T-cell biology, which is required to deliver a variety of therapeutics that specifically harness or manipulate T-cell immunity in a number of disease areas, including cancer, assisting the life sciences sector in developing a variety of therapies and vaccination strategies.

Business identity

Contact email
[email protected]
Phone number
46841080757
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2014-10-23

Headquarters

Postal code
15136
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
4
Total equity funding
$129.9M
Last funding
Series Unknown / $46M / 2025-08-18
Last equity funding
Series Unknown / $46M
Investors
9
Lead investors
3
Founders
1
Articles
44

Founders and investors

Founders

Reagan Jarvis

Lead investors

AMFEuropean Investment BankMellby Gård AB

Investors

AMFEuropean Investment BankNidocoRamsbury Invest ABSwedbank Robur